Given the separation of Prc1+ and MFAP2+ populations, we next tested whether these groups were differentially vulnerable to ZIKV infection by multiplexing RNAscope probes against Prc1, MFAP2, and ZIKV. This evidence concerns the gene MFAP2 and Zika virus infectious disease.